Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00826514 · ClinicalTrials.gov registry record · Phase 2
An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis
A Phase 2 study of Chronic Prostatitis With Chronic Pelvic Pain Syndrome, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 62
- Enrollment target
- 20
- Study locations
NCT00826514: Completed Phase 2 study of Chronic Prostatitis With Chronic Pelvic Pain Syndrome, sponsored by Pfizer.
NCT00826514 is a Phase 2 study of Chronic Prostatitis With Chronic Pelvic Pain Syndrome that has completed, run by Pfizer. The registered enrollment target is 62 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (53% lower). The trial reports 20 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00826514, a Phase 2 study of Chronic Prostatitis With Chronic Pelvic Pain Syndrome, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 62 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to determine whether tanezumab is effective in the treatment of pain associated with chronic prostatitis.
Primary Outcome
Participants assessed average chronic prostatitis pain in the last 24 hours on an 11-point numeric rating scale (NRS) ranging from 0 (no chronic prostatitis pain) to 10 (chronic prostatitis pain as bad as you can imagine). The average daily pain score was calculated as the mean of the scores over the last 7 days prior to each assessment time point. Higher score indicated severe pain.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Tanezumab
Study Locations (20)
California
- Clinical Innovations, Inc. - Costa Mesa
- Citrus Valley Medical Research Inc. - Glendora
- Atlantic Urological Medical Group Incorporated - Long Beach
- Orange Coast Urology - Newport Beach
- Los Angeles Infertility and Prostatitis Medical Group - Santa Monica
Alabama
- Alabama Research Center, LLC - Birmingham
- The Kirklin Clinic - Birmingham
- University of Alabama Birmingham - Birmingham
Florida
- Specialists in Urology - Bonita Springs
- Specialists in Urology - Naples
- Pinellas Urology, Inc. - St. Petersburg
New York
- Hudson Valley Urology, PC - Kingston
- University Urology Associates - New York
- Hudson Valley Urology, PC - Poughkeepsie
Arizona
- Valley Urologic Associates - Goodyear
- Dedicated Clinical Research - Litchfield Park
Ohio
- Tri-State Urologic Services PSC, Inc. dba The Urology Group - Cincinnati
- Cleveland Clinic - Cleveland
Louisiana
- Regional Urology, LLC - Shreveport
Nebraska
- Quality Clinical Research - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2009-03-25 |
| Est. Completion | 2010-03-17 |
| Phase | Phase 2 |
What the finished NCT00826514 record still lists
NCT00826514 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (53% lower).
The record links to 1 condition, with Chronic Prostatitis With Chronic Pelvic Pain Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00826514 names 20 study sites across 8 states, led by California, Alabama, Florida.
Frequently Asked Questions
What is clinical trial NCT00826514 about?
NCT00826514 is a clinical study titled "An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis". The purpose of this study is to determine whether tanezumab is effective in the treatment of pain associated with chronic prostatitis.
What is the current status of trial NCT00826514?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 62 participants. The study started on 2009-03-25. Estimated completion is 2010-03-17.
What conditions does trial NCT00826514 study?
This clinical trial studies the following conditions: Chronic Prostatitis With Chronic Pelvic Pain Syndrome.
What interventions are being tested in trial NCT00826514?
The interventions under investigation include: Placebo (DRUG), Tanezumab (DRUG).
Who is sponsoring clinical trial NCT00826514?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00826514 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00826514's enrollment target sits among peer trials
62 1016th of 2000 higher than 975 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI